A perspective for chronic obstructive pulmonary disease (COPD) management: six key clinical questions to improve disease treatment-Reference-Cited by-同舟云学术

A perspective for chronic obstructive pulmonary disease (COPD) management: six key clinical questions to improve disease treatment

Published:2020-10-06 Issue:4 Volume:22 Page:427-437
ISSN:1465-6566
Container-title:Expert Opinion on Pharmacotherapy
language:en
Short-container-title:Expert Opinion on Pharmacotherapy

Author:

Contoli Marco¹^ORCID,Morandi Luca¹,Di Marco Fabiano²,Carone Mauro³

Affiliation:

1. Department of Morphology, Surgery and Experimental Medicine, Università Di Ferrara, Ferrara, Italy

2. Department of Health Science, Università degli studi di Milano, Respiratory Unit, ASST Papa Giovanni XXIII, Bergamo, Italy

3. Division of Pneumology, Istituti Clinici Scientifici Maugeri IRCCS, Pavia, Italy

Funder

Boehringer Ingelheim

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/14656566.2020.1828352

Reference114 articles.

1. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

2. Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and the prevention of chronic obstructive pulmunary disease. 2020 Report. [cited 2020 Sep 7]. https://goldcopd.org/wp-content/uploads/2019/11/GOLD-2020-REPORT-ver1.0wms.pdf

3. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Rational use of inhaled corticosteroids for the treatment of COPD;npj Primary Care Respiratory Medicine;2023-07-24

2. Wenshen Yiqi Keli Mitigates the Proliferation and Migration of Cigarette Smoke Extract-Induced Human Airway Smooth Muscle Cells through miR-155/FoxO3a Axis;Evidence-Based Complementary and Alternative Medicine;2022-11-22

3. Methylprednisolone up-regulates annexin A1 (ANXA1) to inhibit the inflammation, apoptosis and oxidative stress of cigarette smoke extract (CSE)-induced bronchial epithelial cells, a chronic obstructive pulmonary disease in vitro model, through the formyl peptide receptor 2 (FPR2) receptors and the adenosine 5’-monophosphate (AMP)-activated protein kinase (AMPK) pathway;Bioengineered;2022-02-01

4. The Effects of Inhaled Airway Directed Pharmacotherapy on Decline in Lung Function Parameters Among Indigenous Australian Adults With and Without Underlying Airway Disease;International Journal of Chronic Obstructive Pulmonary Disease;2021-09